Elon Musk's Neuralink has received FDA clearance for its experimental Blindsight device, designed to restore vision by targeting the brain's visual cortex.

Neuralink recently announced that it has received "Breakthrough Device Designation" from the FDA for Blindsight, a device designed to restore vision to those who can no

Elon Musk's brain-chip startup Neuralink announces its experimental implant can restore vision, receives US FDA 'breakthrough device' designation.

Neuralink, a brain-computer interface company founded by Elon Musk, has announced a groundbreaking Blindsight implant that could restore vision to individuals who have lost both eyes. Musk shared this news on Wednesday,

Elon Musk’s brain-chip company, Neuralink, has unveiled a new experimental device called Blindsight, aimed at restoring vision for the blind. The U.S. Food and Drug Administration (FDA) granted the device “breakthrough” status on September 17, placing it among the most advanced medical technologies designed to treat severe health conditions.

Elon Musk's company, Neuralink, has developed a new brain implant called "Blindsight" that could potentially restore vision for some people with visual impairments.

Blindsight is distinct from another Neuralink project known as Telepathy, which is designed to allow patients with spinal cord injuries to control computers using their thoughts

The experimental implant received the FDA's "breakthrough device" designation, with founder Elon Musk highlighting its potential to restore vision, even for those blind from birth

The regulatory approval is just the first phase of a long project, but Neuralink owner Elon Musk is already touting his brain implant tech as a world-changing solution for people with vision loss.